Risk factor | Post-primary | ||
---|---|---|---|
OR | 95% CI | p value | |
Age | |||
 < 5 | 1 |  |  |
 6–15 | 1.69 | 1.46–1.96 | < 0.001 |
 16–30 | 1.80 | 1.53–2.11 | < 0.001 |
 > 31 | 1.91 | 1.54–2.38 | < 0.001 |
Sex | |||
 Female | 1 |  |  |
 Male | 0.94 | 0.85–1.04 | 0.248 |
Disease day | |||
 1–2 | 1 |  |  |
 3–4 | 1.06 | 0.94–1.19 | 0.377 |
 5 | 1.00 | 0.84–1.19 | 0.973 |
Clinical manifestation | |||
 No warning signs | 1 |  |  |
 Warning signs | 1.47 | 1.28–1.70 | < 0.001 |
 Severe | 1.66 | 1.28–2.16 | < 0.001 |
 Non-disclosed | 0.90 | 0.76–1.07 | 0.227 |
DRU elevation (metres) | |||
 0–75 | 1 |  |  |
 75–150 | 0.81 | 0.67–0.97 | 0.023 |
 150+ | 0.61 | 0.52–0.72 | < 0.001 |
DRU pop den (km2) | |||
 0–100 | 1 |  |  |
 100–200 | 0.87 | 0.77–0.97 | 0.017 |
 200+ | 1.32 | 1.14–1.53 | < 0.001 |